NCT03644134

Brief Summary

Globally, type 2 diabetes mellitus (DM) and obesity are considered to be the fastest growing disorders and their prevalence has increased dramatically over the last twenty years. Recent studies have shown that about 19% of UAE population has been diagnosed with DM and 57% of Emirati patients with type 2 DM are obese. Optimal glycemic control and weight management involve comprehensive lifestyle approaches including nutrition recommendations and adequate levels of physical activity. However, recent views have suggested that there are other factors, such as sleep deprivation and stress, contribute to development of type 2 DM. Taking into account the previous findings, the present study was designed to investigate the effects of a personalized intervention on weight and glycemic control in Emirati patients with type 2 DM. The intervention involves assessment and modification of sleep patterns and stress levels.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for not_applicable type-2-diabetes-mellitus

Timeline
Completed

Started Sep 2013

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 26, 2013

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 5, 2014

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 14, 2015

Completed
3.1 years until next milestone

First Submitted

Initial submission to the registry

August 18, 2018

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 23, 2018

Completed
Last Updated

August 23, 2018

Status Verified

August 1, 2018

Enrollment Period

8 months

First QC Date

August 18, 2018

Last Update Submit

August 22, 2018

Conditions

Keywords

Type 2 Diabetes, Physiological Stress, Sleep Pattern

Outcome Measures

Primary Outcomes (3)

  • Change in body weight

    Measurement of body weight at the site visit pre/post the intervention

    6 months

  • Change in BMI

    Measurement of BMI at the site visit pre/post the intervention

    6 months

  • Change in HbA1c

    Measurement of HbA1c at the site visit pre/post the intervention

    6 month

Study Arms (2)

Intervention Group

EXPERIMENTAL

Assessment of physiological stress and sleep pattern intervention consists of (i) information session (ii) pre-assessment (first assessment) of stress and recovery levels, and sleep patterns (iii) individual feedback sessions and action plans based on the outcomes of the initial assessment (iv) monitoring and follow-ups (v) post-assessment (second assessment) of stress and recovery levels and sleep patterns

Behavioral: Assessment of physiological stress and sleep pattern

Control Group

NO INTERVENTION

The control protocol only includes (i) information session (ii) pre-assessment (initial assessment and (iii) post-assessment (second assessment) of stress and recovery levels and sleep patterns.

Interventions

The personalized intervention consists of (i) information session (ii) pre-assessment (first assessment) of stress and recovery levels, and sleep patterns (iii) individual feedback sessions and action plans based on the outcomes of the initial assessment (iv) monitoring and follow-ups (v) post-assessment (second assessment) of stress and recovery levels and sleep patterns.

Intervention Group

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age between 18-60 years
  • Body Mass Index (BMI \> 25 Kg/m2)
  • T2DM

You may not qualify if:

  • Age \< 18 and \> 60 years
  • BMI \< 25 Kg/m2)
  • Type 1 DM
  • Diagnosis of atrial fibrillation and/or atrial flutter and/or bundle branch block heart transplantation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Diabetes Mellitus, Type 2

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 18, 2018

First Posted

August 23, 2018

Study Start

September 26, 2013

Primary Completion

June 5, 2014

Study Completion

July 14, 2015

Last Updated

August 23, 2018

Record last verified: 2018-08

Data Sharing

IPD Sharing
Will not share